Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Lantern Pharma Inc.
LTRN · SEC Filings
website
16
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug develop...
Price
0.599
Market Cap
8.96 M
Float
14.79 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about LTRN
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Lantern Pharma Inc.
LTRN · SEC Filings
14.79 M
Float
0.599
Price
8.96 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2026
10-K/A
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 30, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
424B5
REGISTERED OFFERING
Sep 30, 2026
424B5
REGISTERED OFFERING
May 14, 2026
424B5
PENDING FIXED PRICE OFFERING | Bank: ThinkEquity LLC
Mar 30, 2026
424B5
July 2025 ATM | Amount sold to date: $0 | Float: 10,784,725
Jul 3, 2025
424B4
4,285,715 Shares-
Jan 15, 2021
424B4
OFFERING | Shares amount: 1,750,000 | Share price: $15.00 | Offering amount: $26,250,000.00
Jun 12, 2020
Registrations
TYPE
HEADLINE
FILED AT
S-1
SHARE RESALE REGISTRATION
Jun 12, 2026
D
Form D - Notice of Exempt Offering of Securities - Item 06b
May 21, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
May 24, 2024
S-3
SHELF | Offering amount: $150,000,000.00 EFFECTIVE
May 24, 2024
S-3
SHELF | Offering amount: $200,000,000.00 EFFECTIVE
Jul 2, 2021
S-1MEF
Registration-
Jan 15, 2021
Proxies
TYPE
HEADLINE
FILED AT
DEF 14A
Form DEF 14A - Other definitive proxy statements
Oct 19, 2026
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Oct 8, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Aug 8, 2025
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Jul 28, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 29, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 27, 2023
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
Empery Asset Management, LP (Filed by)
Oct 13, 2026
SCHEDULE 13G
Empery Asset Management, LP (Filed by)
Aug 4, 2026
SCHEDULE 13G/A
SATTERFIELD THOMAS A JR (Filed by)
Jul 23, 2026
SCHEDULE 13D/A
Bios Equity Partners, LP (Filed by)
May 15, 2026
4
Schalop Lee Troy (Reporting)
May 14, 2026
4
KEYSER D JEFFREY (Reporting)
May 14, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Jun 22, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Jun 11, 2024
CORRESP
Form CORRESP - Correspondence
Jun 6, 2024
LETTER
Form UPLOAD - SEC-generated letter
Jun 3, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Jul 13, 2021
CORRESP
Form CORRESP - Correspondence
Jul 8, 2021
